SCHEMBL4769555

SCHEMBL4769555

O=c1c([N+](=O)[O-])c(C=Cc2cnn(-c3ccccc3)c2)n(C(F)c2ccccc2)c(=O)n1C(F)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.37
MTOR P42345 2/20 0.36
RPTOR Q8N122 1/20 0.35
MLST8 Q9BVC4 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
MITF O75030 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
POLB P06746 1/20 0.33
MGAM O43451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769549 1.00 NPC1 (0.41) NPC1RAB9ASMN1; SMN2HSP90AA1MTOR
SCHEMBL4762428 0.87 MAPT (0.39) RAB9ASMN1; SMN2ALDH1A1MAPTMAPK1
SCHEMBL4762430 0.87 MAPT (0.39) RAB9ASMN1; SMN2ALDH1A1MAPTMAPK1
SCHEMBL4762612 0.86 NPC1 (0.41) NPC1RAB9ASMN1; SMN2HSP90AA1MTOR
SCHEMBL4762617 0.86 NPC1 (0.41) NPC1RAB9ASMN1; SMN2HSP90AA1MTOR
SCHEMBL4767864 0.85 MAPT (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4767868 0.85 MAPT (0.40) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4766270 0.83 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2HSP90AA1MTOR
SCHEMBL4766280 0.83 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2HSP90AA1MTOR
SCHEMBL4764062 0.81 MAPT (0.37) SMN1; SMN2ALDH1A1MAPTMAPK1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed